Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Taiwan To Double Stockpile Of Tamiflu, Relax Regs For Flu Drugs

This article was originally published in PharmAsia News

Executive Summary

Taiwan health authorities decided to increase the nation's supply of Roche's Tamiflu (oseltamivir) - enough to treat 7 million against the H1N1 flu virus. A stockpile that size would be enough to treat about 30 percent of Taiwan's population, beyond the current supply able to treat 14 percent. The flu-prevention task force also decided to relax some regulations to allow expanded use of the antiviral as the peak season for the flu neared Taiwan. The country also has a stockpile of shikimic acid, the active pharmaceutical ingredient in Tamiflu, enough to cover 4 percent. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts